Glucagon imeze nka peptide-1 (GLP-1) ni imisemburo ikomeye mu kugenzura umubiri isukari mu maraso no kurya. Ifite uruhare runini mumikorere ya metabolike, cyane cyane murwego rwo gucunga ibintu nka diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije. GLP-1 ikora nka hormone ya incretin, igira uruhare mu gusohora insuline, ikabuza glucagon kurekura, no guteza imbere guhaga. Ubushobozi bwayo bwo kuvura bwatumye GLP-1 yakira reseptor agonist, icyiciro cyimiti ikoreshwa cyane mukuvura indwara ziterwa na metabolike. Iyi miti yahinduye imiterere ya diyabete no kuvura umubyibuho ukabije, itanga ibisubizo bifatika byo kunoza glucose yamaraso no gucunga ibiro. Muri iki kiganiro, tuzasesengura uburyo bwa GLP-1, uburyo bukoreshwa mu mavuriro, hamwe n’umutekano n’ingirakamaro by’imiti ishingiye kuri GLP mu buvuzi bugezweho.
Uburyo bwa GLP-1
GLP-1 ni imisemburo ya peptide ikorwa cyane cyane mu mara, cyane cyane muri L-selile. Iyo ibiryo bimaze gufata, GLP-1 isohoka mu maraso, aho igira ingaruka nyinshi zigamije kubungabunga glucose homeostasis. Imwe mu nshingano zingenzi za GLP-1 iri mumabwiriza yo gusohora insuline. Iyo glucose yinjiye mumaraso nyuma yo kurya, GLP-1 itera pancreas kurekura insuline. Iyi insuline ifasha selile kwinjiza glucose, igabanya urugero rwisukari mu maraso. Izi ngaruka ni ingenzi cyane cyane kubantu barwaye diyabete yo mu bwoko bwa 2, aho ubushobozi bwumubiri bwo gukora cyangwa kwitabira insuline bubangamiwe.
Usibye gutera insuline gusohora, GLP-1 ibuza glucagon kurekura pancreas. Glucagon ni imisemburo yerekana umwijima kurekura glucose yabitswe mumaraso. Muguhagarika glucagon, GLP-1 irinda umusaruro mwinshi wa glucose, bikanafasha mukugenzura isukari yamaraso. Iki gikorwa cyibiri-gikangura insuline no guhagarika glucagon-gifasha kugumana urugero rwiza rwamaraso glucose, cyane cyane nyuma yo kurya.
Ikindi gikorwa cyingenzi cya GLP-1 ningaruka zacyo mugusiba gastrica no guhaga. GLP-1 idindiza inzira yo gusiba gastric, ifasha abantu kumva bahaze igihe kinini nyuma yo kurya. Ibi byagabanije gusiba gastric, bifatanije no kwiyongera mubyiyumvo byuzuye (guhaga), bigira uruhare mukurinda ubushake bwo kurya. Izi ngaruka zituma GLP-1 igirira akamaro cyane abantu bafite umubyibuho ukabije, kuko ibafasha gucunga ibiryo bya calorie.
Bakora bate?
Imiti ishingiye kuri GLP, izwi kandi ku izina rya GLP-1 reseptor agonist, ni icyiciro cy'imiti yigana ingaruka kamere z'umusemburo glucagon umeze nka peptide-1 (GLP-1). GLP-1 ikorerwa mu mara nyuma yo gufata ibiryo kandi ikagira uruhare runini muguhindura urugero rwa glucose yamaraso, appetit, na insuline. Iyi miti ihuza reseptor ya GLP-1 kuri selile zitandukanye mumubiri, bigatera ibisubizo bisa neza nibikorwa bisanzwe bya GLP-1. Intego yabo y'ibanze ni ukugabanya kunoza igenzura rya glucose no kugabanya ibiro byumubiri kubantu barwaye diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije.
Iyo GLP-1 yakira reseptor agoniste, ifasha kongera imisemburo ya insuline mugusubiza amafunguro, kubuza irekurwa rya glucagon (imisemburo itera glucose yamaraso), no gusohora gazi gahoro, bigatuma ibyiyumvo byuzuye byuzuye. Izi ngaruka zose hamwe zituma imiti ya GLP-1 ikora neza cyane mugucunga isukari yamaraso no gushyigikira imbaraga zo kugabanya ibiro.
Bimwe mubisanzwe byandikirwa GLP-1 reseptor agonist harimo semaglutide, liraglutide, na exenatide. Buri miti muri iyo miti iratandukanye mubijyanye na farumasi (uburyo umubiri winjiza, ukwirakwiza, metabolize, kandi usohora imiti), ingengabihe yo gukoresha, hamwe nuburyo bukoreshwa, bitanga uburyo bworoshye kubashinzwe ubuvuzi mukuvura abarwayi bafite ibibazo bitandukanye.
Semaglutid (Ozempic, Wegovy) : Semaglutid numwe mubantu bazwi cyane ba GLP-1 bakira agoniste. Byagaragaye ko bigabanya cyane urwego rwa HbA1c (ikimenyetso cyo kugenzura amaraso maremare maremare glucose) kandi bigatera kugabanuka cyane. Mubisanzwe bitangwa rimwe mucyumweru, biha abarwayi gahunda yo gufata neza, bigatuma ihitamo kubantu bafite imibereho myinshi cyangwa abasanga inshinge za buri munsi bitoroshye.
Liraglutide (Victoza, Saxenda) : Liraglutide nubundi buryo bukoreshwa cyane na GLP-1 agonist, buboneka muburyo bubiri-Victoza ya diyabete na Saxenda yo kugabanya ibiro. Iyi miti itangwa buri munsi kandi yerekanye akamaro gakomeye mugutezimbere glycemic no gushyigikira imicungire yuburemere kubantu barwaye diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije.
Exenatide (Byetta, Bydureon) : Exenatide yari umwe mubambere ba GLP-1 ba reseptor agoniste bemewe gukoreshwa mu kuvura diyabete yo mu bwoko bwa 2. Iraboneka muburyo bubiri: Byetta, itangwa kabiri kumunsi, na Bydureon, inshinge rimwe mubyumweru. Izi mikorere zombi zifasha gucunga glucose yamaraso no gutanga inyungu zo kugabanya ibiro.
Iyi miti yigana cyane imikorere y’ibinyabuzima ya GLP-1 kandi itanga inyungu nyinshi kubantu barwaye diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije. Mugucunga neza isukari yamaraso no gufasha kugabanya ibiro, bigira uruhare runini mukuzamura ubuzima bwimikorere nubuzima rusange kubarwayi.
Imikoreshereze yubuvuzi bwa GLP-1 Ibiyobyabwenge
Kuvura Diyabete yo mu bwoko bwa 2
GLP-1 reseptor agonist byagaragaye ko ifite akamaro kanini mugucunga diyabete yo mu bwoko bwa 2. Mu kongera imisemburo ya insuline no kubuza glucagon gusohora, iyi miti itezimbere glucose yamaraso, cyane cyane nyuma yo kurya. Imiti ya GLP-1 ikoreshwa kenshi mu rwego rwo kuvura indwara ya diyabete yo mu bwoko bwa 2, cyane cyane iyo indi miti (nka metformine) idahagije kugira ngo igabanye urugero rw'isukari mu maraso.
Mu bigeragezo bivura, GLP-1 yakira reseptor agoniste nka semaglutide na liraglutide yerekanye ko igabanuka rikabije rya HbA1c, rikaba ari ingenzi cyane mu gukumira indwara ya diyabete yamara igihe kirekire. Byongeye kandi, iyi miti ifasha kugabanya umuvuduko wamaraso glucose, igenzura buri gihe isukari yamaraso umunsi wose.
Uruhare mugucunga umubyibuho ukabije no guhindagurika
GLP-1 yakira agoniste ntabwo ari ingirakamaro mu gucunga diyabete yo mu bwoko bwa 2-byagaragaye kandi ko ifite akamaro kanini mu kuvura umubyibuho ukabije. Ibiyobyabwenge nka semaglutide (Wegovy) byemerewe na FDA kubwo kugabanya ibiro kubera ubushobozi bwabo bwo guhagarika ubushake bwo kurya no guteza imbere amavuta. Mu kongera ibyiyumvo byuzuye no kugabanya inzara, imiti ya GLP-1 ifasha abantu guhitamo ibiryo byiza no kugabanya ibyo kurya muri rusange.
Byongeye kandi, imiti ya GLP-1 yagiye ifitanye isano n’imikorere myiza yumutima nimiyoboro y'amaraso ku barwayi bafite umubyibuho ukabije. Ku bantu barwaye syndrome de metabolike, ikubiyemo ihuriro ryimiterere nkumuvuduko ukabije wamaraso, ibinure byinshi bikikije ikibuno, hamwe na cholesterol nyinshi, imiti ya GLP-1 itanga uburyo bwuzuye bwo gucunga ibintu bitandukanye byiyi ndwara.
Umutekano n'ingaruka z'imiti ya GLP-1
Mugihe imiti ya GLP-1 ifatwa nkumutekano kandi ikora neza, irashobora gutera ingaruka kubantu bamwe. Ingaruka zikunze kugaragara ni gastrointestinal muri kamere, harimo isesemi, kuruka, no gucibwamo. Izi ngaruka akenshi usanga arigihe gito kandi zigabanuka nkuko umubiri umenyera imiti.
Mubihe bidasanzwe, abantu bamwe bashobora guhura ningaruka zikomeye, nka pancreatite cyangwa ibibazo byimpyiko. Ni ngombwa ko abarwayi baganira ku mateka y’ubuvuzi n’abashinzwe ubuzima mbere yo gutangira imiti ya GLP-1 kugira ngo barebe ko ari yo miti ibakwiye.
Iyindi ngaruka ishobora gutera ni hypoglycemia (isukari nke mu maraso), cyane cyane iyo imiti ya GLP-1 ikoreshwa ifatanije nindi miti ya diyabete nka sulfonylure cyangwa insuline. Nyamara, ibyago byo kurwara hypoglycemia hamwe n’imiti ya GLP-1 yonyine ni bike ugereranije n’ubundi buryo bwo kuvura diyabete.
Umwanzuro
Imiti ya GLP-1 yahinduye imiterere ya diyabete yo mu bwoko bwa 2 no kuvura umubyibuho ukabije, itanga igisubizo cyiza cyo gucunga isukari mu maraso no guteza imbere ibiro. Iyi miti, mu kwigana imisemburo isanzwe ya GLP-1, igenga imisemburo ya insuline, igabanya ubushake bwo kurya, kandi ikagumana glucose homeostasis. Hamwe nibikorwa bigaragara kandi bifite ingaruka nkeya, imiti ya GLP-1 nigikoresho cyingenzi mugukemura ibibazo bya metabolike.
Mugihe ubushakashatsi burimo gukorwa bugaragaza GLP-1 yakira reseptor agoniste, iyi miti yiteguye kuzamura cyane ubuzima bwabantu babarirwa muri za miriyoni barwaye umubyibuho ukabije, diyabete yo mu bwoko bwa 2, hamwe n’ibindi bijyanye. Iyo uhujwe no gukurikirana no kuvura neza, imiti ya GLP-1 itanga inyungu nini mugucunga ubuzima bwimikorere no kuzamura imibereho.
Kubashaka amakuru arambuye kubijyanye nubuvuzi bugezweho nibisubizo mubijyanye nubuzima bwa metabolike, turasaba gusura Cocer Peptides Co., Ltd. Ubuhanga bwabo mubuvuzi bwa peptide hamwe nubuvuzi bwiza butanga ubumenyi bwingenzi mubyagezweho. Waba ushaka uburyo bwo kuvura cyangwa ushaka ubuyobozi bwumwuga, Cocer Peptides Co., Ltd nisoko yizewe kubicuruzwa byubuzima bwiza kandi byiza. Kwegera uyu munsi kugirango umenye byinshi byukuntu bashobora gushyigikira urugendo rwawe rugana ubuzima bwiza.
